Although previous studies have also identified MAPK8 and CAPN1 as biomarkers for IDD [42], KANK2, discovered in this study, is more suitable for blood testing, as stable mRNA and protein fragments of KANK2 are detectable in the blood. This evidence concerns the gene CAPN1 and intervertebral disk degenerative disorder.